'The Pink Sheet'
   
HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact Us


(800) 332-2181

Does your company need a site license or a multiple-user account?
Call (800) 332-1370 and ask for Michael Magoulias.

Click here to sign up for a free trial or to subscribe to "The Pink Sheet" today.



The Pink Sheet
Prescription Pharmaceuticals and Biotechnology

Founded in 1939, "The Pink Sheet" provides in-depth coverage of the prescription pharmaceutical industry. Known as "The Bible" to the prescription pharmaceutical industry, this specialized weekly publication covers regulatory activities of FDA, FTC and CMS; Congress; industry news, such as mergers and acquisitions, new product introductions and executive changes; and financial news, such as companies' sales and earning performance and stock activity. The publication covers research, manufacturing, distribution and the retail sector. Plus, you'll get daily coverage of prescription pharmaceutical and biotechnology news from Health News Daily on the Web at no extra charge.

Rates    

Individual Subscription - 1 Year (Print & Web)

 
$2,035.00

A subscription to "The Pink Sheet" also includes access to HealthNewsDaily.com, your daily source of news in Pharmaceuticals and Biotechnology, Herbals and OTCs, Medical Devices and Diagnostics, and Washington Health Policy.

 

Contact us today to save on a multiple user account or a site license for your company. Call Michael Magoulias at (240) 221-4530, or email him at: M.Magoulias@Elsevier.com.

 

 
Other Pharmaceutical Publications
"The Pink Sheet" DAILY
Health News Daily
"The Gold Sheet"
Pharmaceutical Approvals Monthly
FDAAdvisoryCommittee.com

 


HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact Us
© 2010 FDC Reports | Privacy Policy| Terms of Use